Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-30 20:26:27 - browse：68

Fatty liver foregrounds arteries and veins surrounded by red blood cells — health coverage from STAT — Adobe

As drugmakers race to join the obesity drug market ignited by the approval of Wegovy and Zepbound, they’re not just competing on their drugs’ weight loss effects. They’re also competing on their products’ ability to treat a severe form of liver disease.

A new update of the STAT Obesity Drug Tracker shows that at least 23 — about one-fifth — of the 105 obesity treatments in development or on the market are also being investigated for metabolic dysfunction-associated steatohepatitis, the fatty liver disease known as MASH (and previously called NASH).

In this update, STAT has added a category — “other diseases investigated” — to show conditions beyond obesity for which a compound is being studied. Type 2 diabetes is the most common – it’s long been linked to obesity, and the latest GLP-1 treatments like Wegovy and Zepbound were initially developed as diabetes drugs. But behind diabetes, the next most common disease under investigation for obesity candidates is MASH.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

leisure time

WSS

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Report cites 'urgent' need to recruit more diverse clinical trial participants

Medical records are filled with copy

Study gives hint on South Asians’ higher risk of cardiovascular disease

Activists slam private health insurers over coverage restrictions

focus

Wikipedia

explore

As demand for Covid shots wanes, Moderna seeks its next success

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medical leaders decry Supreme Court decision on affirmative action

Having children helps parents live longer, especially after age 80

In age of alternative facts, a scholarly course on calling out crap

Sports medicine is finally prioritizing gender equality

Medicare proposal to cover medical devices draws a mixed reaction

Latigo launches with $135 million for Vertex

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

Doctors on social media are being harassed and cyberbullied

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Congress considering partial increase for doctor pay in Medicare

After affirmative action ruling, medical educators look to 'holistic review'

Medical records are filled with copy

entertainment

focus

leisure time

entertainment